SCHEMBL18853499

SCHEMBL18853499

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4cccc(-c5nc(-c6cccc7ccccc67)nc6sc7ccc8ccccc8c7c56)c4)c3)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.35
▸ MAPT P10636 4/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ HPGD P15428 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ MAP3K8 P41279 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18853502 0.98 ALDH1A1 (0.35) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853468 0.92 ADORA2A (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853328 0.91 ALDH1A1 (0.38) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853488 0.91 ADORA2A (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853413 0.91 ADORA2A (0.36) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853497 0.91 ADORA2A (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853538 0.90 ALDH1A1 (0.38) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853323 0.90 ALDH1A1 (0.38) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL18853302 0.90 ADORA2A (0.36) MAPTHPGDMAPK1ATMTDP1
SCHEMBL18853319 0.90 ADORA2A (0.39) ALDH1A1MAPTKDM4EHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 ALDH1A1 69/4885MAPT 1935/4885KDM4E 3232/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 ALDH1A1 69/4885MAPT 1935/4885KDM4E 3232/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback